Whole-exome sequencing was performed on the proband (Fig.
1A, III-1) to discover the causative variant. A novel stop-gain pathogenic variant, c.968G > A, was found in the seventh exon of
KCNQ1. This variant substituted tryptophan at site 323 for a stop codon, proposed to cause a premature KCNQ1 truncated protein and/or nonsense-mediated KCNQ1 mRNA decay. Notably, the variant has not yet been reported either in the 1000 Genomes Project, ExAc, gnomAD, HGMD, and ClinVar or in publications. According to the ACMG, c.968G > A was determined as a pathogenic variant (criteria: PVS1, PM2, PP1, and PP4). This nonsense variant was considered the cause of the disease by SIFT, PolyPhen-2, PROVEAN, FATHMM, and GERP + + . The CADD Phred score was 41. The variant was confirmed in the proband (Fig.
1A, III-2) by PCR and Sanger sequencing in the heterozygous state. It was also detected in the proband’s affected brother (Fig.
1A, III-2) and the suspected mother (Fig.
1A, II-4) as a heterozygote. The father (Fig.
1A, II-3) had a normal sequence at this position (Fig.
1B). DNA from the other pedigree members was unavailable. A schematic secondary structure of the KCNQ1 protein is presented in Fig.
1C. In addition, based on the CLUSTALW results, tryptophan323 was located in the conserved part of the KCNQ1 protein (Fig.
1D).